Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for easing pain and use thereof

A composition and drug technology, applied in the direction of drug combination, drug delivery, active ingredients of heterocyclic compounds, etc., can solve the problems of slow onset of action, poor permeability, etc., achieve smooth defecation, quick onset of action, and reduce the pain of patients

Inactive Publication Date: 2013-08-14
临江市妇幼保健院
View PDF1 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But poor permeability, slow onset

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] Under sterile conditions, take 2 ml of methylene blue injection with a mass concentration of 2%, 5 ml of bupivacaine hydrochloride injection with a mass concentration of 0.5%, and 5 ml of lidocaine hydrochloride injection with a mass concentration of 2%. , 16 ml of water for injection and mix well. The methylene blue injection used in the present invention is produced by Jiangsu Jichuan Pharmaceutical Co., Ltd. The bupivacaine injection used in the present invention is the bupivacaine hydrochloride injection produced by Shandong Hualu Pharmaceutical Co., Ltd. The lidocaine injection used in the present invention is the lidocaine hydrochloride injection that Shandong Hualu Pharmaceutical Co., Ltd. produces.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a pharmaceutical composition for easing pain. The pharmaceutical composition is prepared from the following components according to the volume ratio: 2% methylthioninium chloride injection, 0.5% bupivacaine hydrochloride injection, 2% lidocaine hydrochloride injection and water for injection, of which the ratio is 2:5:5:16. The pharmaceutical composition relieves pain after being applied to an anorectal postoperative incision, improves local blood circulation, benefits for wound concrescence, contributes to wound bleeding, and reduces secreta. The pharmaceutical composition does not generate systemic adverse reaction after an operation, local edema or necrosis by a clinical test, and has no influence on local granulation tissue growth and wound concrescence; the anus has no abnormity, can smoothly defecate after the wound is repaired, has no untoward effect after follow-up treatment, and is reliable in curative effect. The drug disclosed by the invention removes a local hot pain after methylenum coeruleum is injected, does not generate an anesthesia clearance, is fast to take effect, and takes effect after being injected 2-4 hours; the reversible nerve damage disappears after about 15 days in general; and the requirement of wound growth just can be met.

Description

technical field [0001] The invention relates to the field of pharmaceutical preparations, in particular to an analgesic pharmaceutical composition and its application. Background technique [0002] Pain treatment emerged in the 1930s (USA), and it was officially launched in my country in the early 1980s. However, compared with foreign countries, there is still a gap in some aspects, especially the pain treatment of anorectal surgery, which lags behind other surgical specialties. In the 1980s, methylene blue was simply used for postoperative incision injection, and the pain was significantly relieved, but the local burning pain was not significantly relieved. In the 1990s, the combined administration of methylene blue + bupivacaine was used, but its onset was slow, and it took about 4-6 hours to take effect after a slow rise and fall, and there was a heat-like pain 2-4 hours after injection, so Compared with the simple use of methylene blue, there is a significant im...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/5415A61K9/08A61P29/00A61K31/167A61K31/445
Inventor 徐中伟吴亚丽
Owner 临江市妇幼保健院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products